TC
DTIL icon

Tejara Capital’s Precision BioSciences DTIL Stock Holding History

Tejara Capital’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58,752
Closed -$324K – 65
2025
Q3 		$324K Sell
58,752
-100
-0.2% -$479 0.17% 46
2025
Q2 		$247K Sell
58,852
-1,575
-3% -$7.77K 0.11% 69
2025
Q1 		$288K Buy
60,427
+39,242
+185% +$200K 0.11% 74
2024
Q4 		$80.7K Sell
21,185
-3,173
-13% -$23.2K 0.05% 52
2024
Q3 		$218K Sell
24,358
-409
-2% -$3.94K 0.1% 52
2024
Q2 		$241K Hold
24,767
– – 0.09% 62
2024
Q1 		$336K Hold
24,767
– – 0.12% 70
2023
Q4 		$271K Buy
24,767
+11,480
+86% +$124K 0.11% 62
2023
Q3 		$136K Buy
13,287
+6,667
+101% +$102K 0.08% 63
2023
Q2 		$104K Sell
6,620
-370
-5% -$8.46K 0.05% 70
2023
Q1 		$158K Sell
6,990
-1,667
-19% -$54.9K 0.08% 79
2022
Q4 		$309K Buy
+8,657
New +$342K 0.18% 77

Other funds holding DTIL

EAM
Empery Asset Management New York $83M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Tejara Capital's DTIL Position: Q4 2025 in Review

Tejara Capital sold out of Precision BioSciences (DTIL) in Q4 2025, closing a stake of 58,752 shares — an estimated $324K sold.

Tejara Capital first reported a position in DTIL in Q4 2022 and held it in 12 quarters. The position peaked at $336K in Q1 2024. 69 funds tracked by Wall St. Rank hold DTIL as of Q4 2025.

  • Tejara Capital reported no remaining Precision BioSciences position as of Q4 2025 after selling out during the quarter.
  • Tejara Capital sold 58,752 Precision BioSciences shares in Q4 2025, an estimated $324K.
  • Tejara Capital first reported a position in Precision BioSciences in Q4 2022 and held it in 12 quarters.
  • Tejara Capital's Precision BioSciences position peaked at $336K in Q1 2024.
  • 69 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2025.

Based on Tejara Capital's 13F filing for Q4 2025, filed 5 Feb 2026.